New York State Common Retirement Fund Next Cure, Inc. Transaction History

New York State Common Retirement Fund

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$6.74 - $8.02 $984 - $1,170	-146 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$7.6 - $10.28 $48,290 - $65,319	-6,354 Reduced 97.75%	146 $1,000
Q1 2021 May 11, 2021	BUY	$9.81 - $13.88 $7,848 - $11,104	800 Added 14.04%	6,500 $65,000
Q4 2020 Feb 08, 2021	SELL	$9.47 - $12.43 $93,753 - $123,057	-9,900 Reduced 63.46%	5,700 $62,000
Q3 2020 Nov 05, 2020	SELL	$8.15 - $21.17 $11,410 - $29,638	-1,400 Reduced 8.24%	15,600 $137,000
Q2 2020 Aug 07, 2020	BUY	$21.19 - $40.2 $91,117 - $172,860	4,300 Added 33.86%	17,000 $364,000
Q4 2019 Feb 05, 2020	BUY	$25.0 - $92.22 $202,500 - $746,982	8,100 Added 176.09%	12,700 $715,000
Q3 2019 Nov 07, 2019	SELL	$15.73 - $41.6 $39,325 - $104,000	-2,500 Reduced 35.21%	4,600 $142,000
Q2 2019 Aug 09, 2019	BUY	$14.16 - $20.64 $100,536 - $146,544	7,100 New	7,100 $106,000

15.9M

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $37.2M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.